Literature DB >> 18614403

Antihypertensive treatment and dementia prevention.

Ingmar Skoog.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18614403     DOI： 10.1016/S1474-4422(08)70144-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  10 in total

Review 1.  Hypertension, dementia, and antihypertensive treatment: implications for the very elderly.

Authors:  Ruth Peters; Nigel Beckett
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

2.  Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis.

Authors:  Ruth Peters; Sevil Yasar; Craig S Anderson; Shea Andrews; Riitta Antikainen; Hisatomi Arima; Nigel Beckett; Joanne C Beer; Anne Suzanne Bertens; Andrew Booth; Martin van Boxtel; Carol Brayne; Henry Brodaty; Michelle C Carlson; John Chalmers; Maria Corrada; Steven DeKosky; Carol Derby; Roger A Dixon; Françoise Forette; Mary Ganguli; Willem A van Gool; Antonio Guaita; Ann M Hever; David B Hogan; Carol Jagger; Mindy Katz; Claudia Kawas; Patrick G Kehoe; Sirkka Keinanen-Kiukaanniemi; Rose Ann Kenny; Sebastian Köhler; Setor K Kunutsor; Jari Laukkanen; Colleen Maxwell; G Peggy McFall; Tessa van Middelaar; Eric P Moll van Charante; Tze-Pin Ng; Jean Peters; Iris Rawtaer; Edo Richard; Kenneth Rockwood; Lina Rydén; Perminder S Sachdev; Ingmar Skoog; Johan Skoog; Jan A Staessen; Blossom C M Stephan; Sylvain Sebert; Lutgarde Thijs; Stella Trompet; Phillip J Tully; Christophe Tzourio; Roberta Vaccaro; Eeva Vaaramo; Erin Walsh; Jane Warwick; Kaarin J Anstey
Journal:  Neurology       Date:  2019-12-11       Impact factor: 9.910

Review 3.  [Special features of pharmacotherapy in older hypertensive subjects].

Authors:  R Kreutz
Journal:  Internist (Berl)       Date:  2009-04       Impact factor: 0.743

4.  Searching cerebrovascular risk indicators for hypertensive patients: Is Framingham Stroke Risk Profile "the magic bullet"?

Authors:  Andrea Semplicini
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-22       Impact factor: 3.738

5.  Valsartan combination therapy in the management of hypertension - patient perspectives and clinical utility.

Authors:  David T Nash; Michael S McNamara
Journal:  Integr Blood Press Control       Date:  2009-10-28

6.  The association between blood pressure variability (BPV) with dementia and cognitive function: a systematic review and meta-analysis protocol.

Authors: 
Journal:  Syst Rev       Date:  2018-10-15

7.  No clear relationship between antihypertensive class and cognitive function over 12 months in a cohort study of community-dwelling adults aged 80 and over.

Authors:  Ruth Peters
Journal:  Ther Adv Chronic Dis       Date:  2019-01-31       Impact factor: 5.091

Review 8.  Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors.

Authors:  Ruth Peters; John Breitner; Sarah James; Gregory A Jicha; Pierre-Francois Meyer; Marcus Richards; A David Smith; Hussein N Yassine; Erin Abner; Atticus H Hainsworth; Patrick G Kehoe; Nigel Beckett; Christopher Weber; Craig Anderson; Kaarin J Anstey; Hiroko H Dodge
Journal:  Alzheimers Dement (N Y)       Date:  2021-12-08

9.  Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND).

Authors:  Blossom Cm Stephan; Fiona E Matthews; Kay-Tee Khaw; Carole Dufouil; Carol Brayne
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982

10.  Implementing the proclamation of stroke and potentially preventable dementias.

Authors:  Vladimir Hachinski; Detlev Ganten; Daniel Lackland; Reinhold Kreutz; Konstantinos Tsioufis; Werner Hacke
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-09       Impact factor: 3.738
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.